Clinical Trials Directory

Trials / Completed

CompletedNCT01765764

Bimatoprost for the Treatment of Eyebrow Hypotrichosis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
357 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).

Conditions

Interventions

TypeNameDescription
DRUGbimatoprost solutionBimatoprost solution once a day or twice a day applied to each eyebrow for 7 months.
DRUGVehicle to bimatoprost solutionVehicle to bimatoprost solution once or twice a day applied to each eyebrow for 7 months.

Timeline

Start date
2013-03-13
Primary completion
2014-01-31
Completion
2014-02-11
First posted
2013-01-10
Last updated
2019-04-23
Results posted
2015-01-26

Locations

2 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01765764. Inclusion in this directory is not an endorsement.

Bimatoprost for the Treatment of Eyebrow Hypotrichosis (NCT01765764) · Clinical Trials Directory